https://novapharmanews.com/eu/news/isct-2026-annual-recap 2026-05-20T18:22:53.223Z NovaPharmaNews en-GB 2026-05-20T13:36:09.234Z ISCT 2026 Annual: Key Highlights and Insights https://novapharmanews.com/uploads/articles/isct-2026-annual-recap.webp ISCT 2026 Annual: Key Highlights and Insights https://novapharmanews.com/us/news/fierce-biotech-week-2026-recap 2026-05-20T17:27:46.457Z NovaPharmaNews en-US 2026-05-20T13:36:09.234Z Fierce Biotech Week 2026: Key Insights and Highlights Fierce, Week https://novapharmanews.com/uploads/articles/fierce-biotech-week-2026-recap.webp Fierce Biotech Week 2026: Key Insights and Highlights https://novapharmanews.com/us/news/oct-east-coast-2026-recap 2026-05-20T18:26:41.199Z NovaPharmaNews en-US 2026-05-20T13:36:09.234Z OCT East Coast 2026: Key Insights and Highlights Coast https://novapharmanews.com/uploads/articles/oct-east-coast-2026-recap.webp OCT East Coast 2026: Key Insights and Highlights https://novapharmanews.com/us/news/thma-cpe-circle-2026-recap 2026-05-20T17:12:50.483Z NovaPharmaNews en-US 2026-05-20T13:36:09.234Z THMA CPE Circle 2026: Key Insights and Highlights Circle https://novapharmanews.com/uploads/articles/thma-cpe-circle-2026-recap.webp THMA CPE Circle 2026: Key Insights and Highlights https://novapharmanews.com/us/news/fda-bayesian-methodology-drug-development 2026-05-20T17:41:39.237Z NovaPharmaNews en-US 2026-05-20T05:03:01.071Z FDA's Bayesian Methodology: A Game Changer for Drug Development https://novapharmanews.com/uploads/articles/fda-bayesian-methodology-drug-development.webp FDA's Bayesian Methodology: A Game Changer for Drug Development https://novapharmanews.com/us/news/sellas-nears-key-aml-data-dual-trials 2026-05-20T17:13:06.909Z NovaPharmaNews en-US 2026-05-20T05:03:01.071Z SELLAS Nears Key AML Data: Insights for Investors and BD Teams acute myeloid leukemia https://novapharmanews.com/uploads/articles/sellas-nears-key-aml-data-dual-trials.webp SELLAS Nears Key AML Data: Insights for Investors and BD Teams https://novapharmanews.com/us/news/new-fda-guidance-ends-nicotine-pouch-products 2026-05-20T17:13:05.167Z NovaPharmaNews en-US 2026-05-20T05:03:01.071Z New FDA Guidance on ENDS and Nicotine Pouch Products https://novapharmanews.com/uploads/articles/new-fda-guidance-ends-nicotine-pouch-products.webp New FDA Guidance on ENDS and Nicotine Pouch Products https://novapharmanews.com/eu/news/global-pharmacovigilance-reporting-comparative-analysis 2026-05-20T18:22:53.971Z NovaPharmaNews en-GB 2026-05-20T05:03:01.071Z Global Pharmacovigilance Reporting: A Comparative Analysis https://novapharmanews.com/uploads/articles/global-pharmacovigilance-reporting-comparative-analysis.webp Global Pharmacovigilance Reporting: A Comparative Analysis https://novapharmanews.com/eu/news/cma-deal-eu-medicine-supply-chains-analysis 2026-05-20T18:22:24.203Z NovaPharmaNews en-GB 2026-05-20T05:02:52.209Z CMA Deal Strengthens EU Medicine Supply Chains https://novapharmanews.com/uploads/articles/cma-deal-eu-medicine-supply-chains.webp CMA Deal Strengthens EU Medicine Supply Chains https://novapharmanews.com/apac/news/asia-pacific-regulatory-updates-tga-guidance 2026-05-20T17:13:35.026Z NovaPharmaNews en-AU 2026-05-20T05:02:52.209Z Asia-Pacific Regulatory Updates: TGA Guidance on Compounded Medicines https://novapharmanews.com/uploads/articles/asia-pacific-regulatory-updates-tga-guidance.webp Asia-Pacific Regulatory Updates: TGA Guidance on Compounded Medicines https://novapharmanews.com/us/news/layoff-tracker-takeda-novartis-restructuring 2026-05-20T16:17:10.645Z NovaPharmaNews en-US 2026-05-20T05:02:29.102Z Layoff Tracker: Takeda and Novartis Restructuring Impact https://novapharmanews.com/uploads/articles/layoff-tracker-takeda-novartis-restructuring.webp Layoff Tracker: Takeda and Novartis Restructuring Impact https://novapharmanews.com/eu/news/europes-drug-innovation-edge-risk-dutch-industry-group 2026-05-20T18:22:51.391Z NovaPharmaNews en-GB 2026-05-20T05:02:29.102Z Europe's Drug Innovation Edge at Risk: Insights from Dutch Industry Group https://novapharmanews.com/uploads/articles/europes-drug-innovation-edge-risk-dutch-industry-group.webp Europe's Drug Innovation Edge at Risk: Insights from Dutch Industry Group https://novapharmanews.com/eu/news/future-european-medicine-clinical-research 2026-05-20T18:12:50.253Z NovaPharmaNews en-GB 2026-05-20T05:02:29.102Z The Future of European Medicine: The Role of Clinical Research https://novapharmanews.com/uploads/articles/future-european-medicine-clinical-research.webp The Future of European Medicine: The Role of Clinical Research https://novapharmanews.com/us/news/fda-approves-atezolizumab-ctdna-mrd-positive-mibc 2026-05-20T18:20:32.185Z NovaPharmaNews en-US 2026-05-20T05:02:29.102Z FDA Approves Atezolizumab for ctDNA MRD-Positive MIBC atezolizumab, oncology, MIBC https://novapharmanews.com/uploads/articles/fda-approves-atezolizumab-ctdna-mrd-positive-mibc.webp FDA Approves Atezolizumab for ctDNA MRD-Positive MIBC https://novapharmanews.com/us/news/biomarin-swot-analysis-rare-disease-biotech 2026-05-20T17:12:47.586Z NovaPharmaNews en-US 2026-05-20T05:02:29.102Z BioMarin's SWOT Analysis: Navigating Competitive Headwinds in Rare Disease Biotech rare disease, rare diseases https://novapharmanews.com/uploads/articles/biomarin-swot-analysis-rare-disease-biotech.webp BioMarin's SWOT Analysis: Navigating Competitive Headwinds in Rare Disease Biotech https://novapharmanews.com/apac/news/shanghai-fosun-pharmaceutical-fda-trial-nod 2026-05-20T17:18:56.896Z NovaPharmaNews en-AU 2026-05-20T05:02:29.102Z Shanghai Fosun Pharmaceutical Stock Surges After FDA Trial Nod https://novapharmanews.com/uploads/articles/shanghai-fosun-pharmaceutical-fda-trial-nod.webp Shanghai Fosun Pharmaceutical Stock Surges After FDA Trial Nod https://novapharmanews.com/us/news/top-10-biopharma-ma-deals-2025 2026-05-20T18:04:16.098Z NovaPharmaNews en-US 2026-05-20T05:02:29.102Z Top 10 Biopharma M&A Deals of 2025: Market Analysis https://novapharmanews.com/uploads/articles/top-10-biopharma-ma-deals-2025.webp Top 10 Biopharma M&A Deals of 2025: Market Analysis https://novapharmanews.com/eu/news/x4-pharmaceuticals-ema-chmp-mavorixafor-approval 2026-05-20T18:22:52.079Z NovaPharmaNews en-GB 2026-05-20T05:02:29.102Z X4 Pharmaceuticals Gains EMA CHMP Support for Mavorixafor Approval Mavorixafor, WHIM Syndrome https://novapharmanews.com/uploads/articles/x4-pharmaceuticals-ema-chmp-mavorixafor-approval.webp X4 Pharmaceuticals Gains EMA CHMP Support for Mavorixafor Approval https://novapharmanews.com/apac/news/risen-pharma-phase-2-trial-rp902-alzheimers 2026-05-20T17:12:59.316Z NovaPharmaNews en-AU 2026-05-20T05:02:29.102Z Risen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's RP902, Alzheimer's disease, Mild Cognitive Impairment, Alzheimer’s Disease https://novapharmanews.com/uploads/articles/risen-pharma-phase-2-trial-rp902-alzheimers.webp Risen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's https://novapharmanews.com/eu/news/breast-cancer-experts-esmo-2026-abstracts-preview 2026-05-20T17:12:44.377Z NovaPharmaNews en-GB 2026-05-19T11:13:46.089Z Breast Cancer Insights: Key Abstracts for ESMO 2026 oncology, breast cancer https://novapharmanews.com/uploads/articles/breast-cancer-experts-esmo-2026-abstracts.webp Breast Cancer Insights: Key Abstracts for ESMO 2026 https://novapharmanews.com/eu/news/first-glp-1-gene-therapy-clinical-trial-europe 2026-05-20T17:30:50.462Z NovaPharmaNews en-GB 2026-05-19T11:13:46.089Z First GLP-1 Gene Therapy Clinical Trial Approved in Europe GLP-1, gene therapy https://novapharmanews.com/uploads/articles/first-glp-1-gene-therapy-clinical-trial-europe.webp First GLP-1 Gene Therapy Clinical Trial Approved in Europe https://novapharmanews.com/apac/news/fierce-pharma-asia-bms-hengrui-deal-takeda-layoffs 2026-05-20T15:39:50.114Z NovaPharmaNews en-AU 2026-05-19T11:13:46.089Z Fierce Pharma Asia: BMS-Hengrui's $15B Deal and More oncology https://novapharmanews.com/uploads/articles/fierce-pharma-asia-bms-hengrui-deal-takeda-layoffs.webp Fierce Pharma Asia: BMS-Hengrui's $15B Deal and More https://novapharmanews.com/us/news/ma-in-pharmaceuticals-market-analysis 2026-05-20T17:13:03.014Z NovaPharmaNews en-US 2026-05-19T11:13:12.276Z M&A in Pharmaceuticals: Bigger, Bolder, and Far More Strategic https://novapharmanews.com/uploads/articles/ma-in-pharmaceuticals-market-analysis.webp M&A in Pharmaceuticals: Bigger, Bolder, and Far More Strategic https://novapharmanews.com/apac/news/kissei-pharmaceutical-halt-tavneos-use-deaths 2026-05-20T18:22:58.478Z NovaPharmaNews en-AU 2026-05-19T11:13:12.276Z Kissei Pharmaceutical Urges Halt on Tavneos Use Amid Deaths Tavneos https://novapharmanews.com/uploads/articles/kissei-pharmaceutical-halt-tavneos-use-deaths.webp Kissei Pharmaceutical Urges Halt on Tavneos Use Amid Deaths https://novapharmanews.com/us/news/new-fda-approach-drug-prices-implications 2026-05-20T18:22:57.803Z NovaPharmaNews en-US 2026-05-19T11:13:12.276Z New FDA Approach to Drug Prices: Implications for Drug Approvals https://novapharmanews.com/uploads/articles/new-fda-approach-drug-prices-implications.webp New FDA Approach to Drug Prices: Implications for Drug Approvals https://novapharmanews.com/us/news/dare-bioscience-phase-2-study-dare-hpv 2026-05-20T18:13:25.621Z NovaPharmaNews en-US 2026-05-19T11:13:12.276Z Daré Bioscience Launches Phase 2 Study for DARE-HPV Treatment DARE-HPV, Persistent High-Risk HPV Infection https://novapharmanews.com/uploads/articles/dare-bioscience-phase-2-study-dare-hpv.webp Daré Bioscience Launches Phase 2 Study for DARE-HPV Treatment https://novapharmanews.com/us/news/fda-approves-atezolizumab-muscle-invasive-bladder-cancer 2026-05-20T18:22:50.319Z NovaPharmaNews en-US 2026-05-19T11:13:12.276Z FDA Approves Atezolizumab for Muscle-Invasive Bladder Cancer Atezolizumab, oncology, Muscle-Invasive Bladder Cancer https://novapharmanews.com/uploads/articles/fda-approves-atezolizumab-muscle-invasive-bladder-cancer.webp FDA Approves Atezolizumab for Muscle-Invasive Bladder Cancer https://novapharmanews.com/us/news/layoff-tracker-takeda-novartis-restructure 2026-05-20T16:17:07.477Z NovaPharmaNews en-US 2026-05-19T11:13:12.276Z Layoff Tracker: Takeda and Novartis Restructure Amid Industry Changes https://novapharmanews.com/uploads/articles/layoff-tracker-takeda-novartis-restructure.webp Layoff Tracker: Takeda and Novartis Restructure Amid Industry Changes https://novapharmanews.com/eu/news/q1-2026-life-sciences-law-update-clinical-trials 2026-05-20T16:13:19.534Z NovaPharmaNews en-GB 2026-05-19T11:13:12.276Z Q1 2026 Life Sciences Law Update: Clinical Trials Insights https://novapharmanews.com/uploads/articles/q1-2026-life-sciences-law-update-clinical-trials.webp Q1 2026 Life Sciences Law Update: Clinical Trials Insights https://novapharmanews.com/apac/news/global-pharmacovigilance-reporting-regulatory-updates 2026-05-20T16:13:38.514Z NovaPharmaNews en-AU 2026-05-19T11:13:12.276Z Global Pharmacovigilance Reporting: Key Regulatory Updates https://novapharmanews.com/uploads/articles/global-pharmacovigilance-reporting-regulatory-updates.webp Global Pharmacovigilance Reporting: Key Regulatory Updates https://novapharmanews.com/apac/news/india-cdsco-prior-intimation-system-clinical-trials 2026-05-20T18:22:23.301Z NovaPharmaNews en-AU 2026-05-18T19:05:42.077Z India's CDSCO Adopts Prior Intimation System for Clinical Trials https://novapharmanews.com/uploads/articles/cdsco-prior-intimation-system-clinical-trials.webp India's CDSCO Adopts Prior Intimation System for Clinical Trials https://novapharmanews.com/apac/news/asia-bacitracin-ointment-market-analysis-regulatory-updates 2026-05-20T18:22:55.964Z NovaPharmaNews en-AU 2026-05-18T19:05:42.077Z Asia Bacitracin Ointment Market Analysis and Regulatory Updates Bacitracin https://novapharmanews.com/uploads/articles/asia-bacitracin-ointment-market-analysis-regulatory-updates.webp Asia Bacitracin Ointment Market Analysis and Regulatory Updates https://novapharmanews.com/eu/news/ema-critical-medicines-act-market-analysis 2026-05-20T18:22:56.794Z NovaPharmaNews en-GB 2026-05-18T19:05:42.077Z EMA's Political Agreement on Critical Medicines Act: Market Implications https://novapharmanews.com/uploads/articles/ema-critical-medicines-act-market-analysis.webp EMA's Political Agreement on Critical Medicines Act: Market Implications https://novapharmanews.com/us/news/big-pharma-ma-mega-year-patent-expiries 2026-05-20T18:13:23.088Z NovaPharmaNews en-US 2026-05-18T19:05:42.077Z Big Pharma M&A Set for Mega Year Amid Patent Expiries https://novapharmanews.com/uploads/articles/big-pharma-ma-mega-year-patent-expiries.webp Big Pharma M&A Set for Mega Year Amid Patent Expiries https://novapharmanews.com/eu/news/regulatory-round-up-may-11-2026 2026-05-20T18:22:59.187Z NovaPharmaNews en-GB 2026-05-18T19:05:42.077Z Regulatory Round-Up: Key Updates from 11 May 2026 https://novapharmanews.com/uploads/articles/regulatory-round-up-11-may-2026.webp Regulatory Round-Up: Key Updates from 11 May 2026 https://novapharmanews.com/us/news/ucb-acquires-antibody-treatment-maker-autoimmune-disease 2026-05-20T15:21:24.150Z NovaPharmaNews en-US 2026-05-18T19:05:42.077Z UCB Acquires Antibody Treatment Maker: Implications for Autoimmune Disease Market autoimmune disease, autoimmune diseases https://novapharmanews.com/uploads/articles/ucb-acquires-antibody-treatment-maker-autoimmune-diseases.webp UCB Acquires Antibody Treatment Maker: Implications for Autoimmune Disease Market https://novapharmanews.com/eu/news/europes-biotech-dilemma-discovery-scale-clinical-trials 2026-05-20T17:12:55.451Z NovaPharmaNews en-GB 2026-05-18T19:05:29.756Z Europe's Biotech Dilemma: Balancing Discovery and Scaling https://novapharmanews.com/uploads/articles/europes-biotech-dilemma-discovery-scale-clinical-trials.webp Europe's Biotech Dilemma: Balancing Discovery and Scaling https://novapharmanews.com/eu/news/x4-pharmaceuticals-ema-chmp-positive-opinion-mavorixafor 2026-05-20T16:13:55.868Z NovaPharmaNews en-GB 2026-05-18T19:05:29.756Z X4 Pharmaceuticals Gains EMA CHMP Positive Opinion for Mavorixafor Mavorixafor, WHIM Syndrome https://novapharmanews.com/uploads/articles/x4-pharmaceuticals-ema-chmp-positive-opinion-mavorixafor.webp X4 Pharmaceuticals Gains EMA CHMP Positive Opinion for Mavorixafor https://novapharmanews.com/us/news/pharma-ma-roundup-april-2026 2026-05-20T18:12:42.821Z NovaPharmaNews en-US 2026-05-18T19:05:29.756Z Pharma M&A Round-Up: April 2026 Insights and Analysis https://novapharmanews.com/uploads/articles/pharma-ma-roundup-april-2026.webp Pharma M&A Round-Up: April 2026 Insights and Analysis https://novapharmanews.com/eu/news/eu-commission-advances-critical-medicines-act 2026-05-20T16:28:22.217Z NovaPharmaNews en-GB 2026-05-18T19:05:29.756Z EU Commission Advances Critical Medicines Act: Market Implications https://novapharmanews.com/uploads/articles/eu-commission-advances-critical-medicines-act.webp EU Commission Advances Critical Medicines Act: Market Implications https://novapharmanews.com/us/news/fda-leadership-changes-crisis-drug-approvals 2026-05-20T18:22:22.401Z NovaPharmaNews en-US 2026-05-18T19:05:29.756Z FDA Leadership Changes Crisis: Implications for Drug Approvals https://novapharmanews.com/uploads/articles/fda-leadership-changes-crisis-drug-approvals.webp FDA Leadership Changes Crisis: Implications for Drug Approvals https://novapharmanews.com/us/news/citius-pharmaceuticals-stock-update-cancer-anti-infective 2026-05-20T16:13:31.925Z NovaPharmaNews en-US 2026-05-18T19:05:29.756Z Citius Pharmaceuticals Stock Update: Cancer and Anti-Infective Pipeline Insights cancer, anti-infective https://novapharmanews.com/uploads/articles/citius-pharmaceuticals-stock-update-cancer-anti-infective.webp Citius Pharmaceuticals Stock Update: Cancer and Anti-Infective Pipeline Insights https://novapharmanews.com/apac/news/the-week-in-pharma-action-reaction-insight-may-15-2026 2026-05-20T17:19:11.155Z NovaPharmaNews en-AU 2026-05-18T19:05:29.756Z The Week in Pharma: Action, Reaction, and Insight – May 15, 2026 oncology https://novapharmanews.com/uploads/articles/the-week-in-pharma-action-reaction-insight-may-15-2026.webp The Week in Pharma: Action, Reaction, and Insight – May 15, 2026 https://novapharmanews.com/us/news/10-clinical-trials-to-watch-2026 2026-05-20T16:30:44.624Z NovaPharmaNews en-US 2026-05-18T19:05:29.756Z 10 Clinical Trials to Watch in the First Half of 2026 https://novapharmanews.com/uploads/articles/10-clinical-trials-to-watch-2026.webp 10 Clinical Trials to Watch in the First Half of 2026 https://novapharmanews.com/us/news/regulatory-round-up-fda-cancer-drug-approvals 2026-05-20T18:22:59.926Z NovaPharmaNews en-US 2026-05-18T19:05:29.756Z Regulatory Round-Up: Key FDA Approvals for Cancer Drugs cancer https://novapharmanews.com/uploads/articles/regulatory-round-up-fda-cancer-drug-approvals.webp Regulatory Round-Up: Key FDA Approvals for Cancer Drugs